ENANTA PHARMACEUTICALS INC

24 de ago. de 2026, 19:06 UTC

Enanta Pharmaceuticals is rising despite recent downgrades, remaining above its 20-day moving average. HC Wainwright maintains a "buy" rating with a $20 target.

21 de ago. de 2026, 19:41 UTC

Enanta Pharmaceuticals is trading higher, supported by gains in biotechnology stocks. The asset remains above its 20-day moving average during Friday's session.

20 de ago. de 2026, 19:31 UTC

Enanta Pharmaceuticals Inc. shares are lower today amid pressure on biotechnology stocks, continuing a decline since Wednesday's close. No specific news was identified.

18 de ago. de 2026, 19:16 UTC

Enanta Pharmaceuticals is trading higher today, supported by a rally in the Biotechnology sub-sector. Shares have gained since Monday's close.

17 de ago. de 2026, 20:06 UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday amid broader market weakness following a drop in U.S. retail sales.

14 de ago. de 2026, 20:06 UTC

Enanta Pharmaceuticals is trading lower amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13 de ago. de 2026, 19:36 UTC

Enanta Pharmaceuticals Inc is trading higher, remaining above its 20-day moving average, despite no specific company news identified for the price movement.

11 de ago. de 2026, 20:06 UTC

Enanta Pharmaceuticals Inc shares are lower today, reflecting broader market declines. The stock reached a session low earlier but has since recovered slightly.

5 de ago. de 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are lower, reflecting broader market sentiment amid disappointing ADP employment data showing a rise of only 44,000 jobs in July.

4 de ago. de 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are higher, buoyed by a decline in crude oil prices that eases inflation concerns. No specific company news was identified.

3 de ago. de 2026, 19:23 UTC

Enanta Pharmaceuticals Inc shares are rising amid a broader market rally, supported by gains in major technology stocks and renewed investor confidence.

31 de jul. de 2026, 20:06 UTC

Enanta Pharmaceuticals Inc's shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and crude oil prices. No specific news was identified.

30 de jul. de 2026, 19:45 UTC

Enanta Pharmaceuticals Inc. is advancing, supported by broader market gains. Earlier in the session, shares pulled back from a session high.

29 de jul. de 2026, 18:26 UTC

Enanta Pharmaceuticals Inc is declining in Wednesday's session, marking the seventh consecutive day of lower prices. No specific news has been identified to explain the movement.

28 de jul. de 2026, 20:06 UTC

Enanta Pharmaceuticals Inc is declining, marking five consecutive sessions lower. The stock peaked earlier but has since pulled back amid broader market pressures.

27 de jul. de 2026, 18:36 UTC

Enanta Pharmaceuticals Inc is higher today, building on Friday's momentum amid broader market dynamics following a decline in oil prices.

24 de jul. de 2026, 20:06 UTC

Enanta Pharmaceuticals Inc. shares are lower today, reversing from a recent trend of higher daily closes since Thursday's close.

21 de jul. de 2026, 19:31 UTC

Enanta Pharmaceuticals is rising during Tuesday's session, reflecting broader market strength and positive sentiment from recent earnings reports by General Motors and Novartis.

20 de jul. de 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday's close. The stock has shown significant volatility during the session.